Compounded Microdose Tirzepatide w/Zofran for Gentle Weight Management
What is Microdosing?
Microdosing refers to using a lower-than-standard dose of compounded Tirzepatide to support gentle, sustained appetite regulation and metabolic balance. Best suited for patients who want long-term lifestyle support, are sensitive to higher dual-agonist doses, or are maintaining results after an initial weight-loss phase.
How It Works
Tirzepatide is a first-of-its-kind dual GIP and GLP-1 receptor agonist. Microdose Tirzepatide activates both pathways at a lower threshold, producing milder versions of the same three effects as standard dosing:
- Modest Appetite Regulation: Reduces food noise without the stronger suppression of higher doses.
- Steady Gastric Emptying: Helps you feel satisfied between meals.
- Improved Glucose & Insulin Response: Stabilizes blood sugar throughout the day.
Key Benefits
- Gentler Side-Effect Profile: Lower nausea risk and milder GI symptoms during titration.
- Maintenance & Lifestyle Support: Ideal for patients in the maintenance phase of weight management.
- Same Telehealth Convenience: Prescribed and shipped after a virtual consultation with a licensed U.S. provider.
Important Precautions
- Personal & Family History: Not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Pancreatitis Risk: Discontinue and seek care if severe abdominal pain develops.
- Common Side Effects: Mild nausea, decreased appetite, fatigue. Generally milder than standard dosing.
- Pregnancy: Not for use during pregnancy or breastfeeding.
Compounded medications are prepared by licensed 503A compounding pharmacies pursuant to a valid prescription. Compounded drugs are not reviewed or approved by the U.S. FDA for safety, effectiveness, or quality as finished drug products. An individual consultation is required to determine whether treatment is appropriate for your health profile.
